Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01769469 · ClinicalTrials.gov registry record
Renal, Endocrine, and Bone Changes in Response to FTC/TDF in Uninfected Young Men Who Have Sex With Men (YMSM).
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 101
- Enrollment target
NCT01769469: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT01769469 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 101 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01769469 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 101 participants
- Enrollment target
Study Summary
This is a prospective observational cohort sub-study of subjects enrolled in the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 110 (NCT01772823) or ATN 113 (NCT01769456), which is a prospective interventional trial.
Primary Outcome
The magnitude of change in PTH will be measured between Baseline and Week 48. For any given variable, at a given time point, the magnitude of change is the fold change compared to the baseline value (if multiplied by 100 would be the percent change from baseline).
Interventions
- DRUG FTC/TDF (Truvada®)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2012-11 |
| Est. Completion | 2015-11 |
What the finished NCT01769469 record still lists
NCT01769469 is an observational study that tracks outcomes without assigning an intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which FTC/TDF (Truvada®) is the first listed.
NCT01769469 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01769469 about?
NCT01769469 is a clinical study titled "Renal, Endocrine, and Bone Changes in Response to FTC/TDF in Uninfected Young Men Who Have Sex With Men (YMSM).". This is a prospective observational cohort sub-study of subjects enrolled in the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 110 (NCT01772823) or ATN 113 (NCT01769456), which is a prospective interventional trial.
What is the current status of trial NCT01769469?
This trial is currently completed. The enrollment target is 101 participants. The study started on 2012-11. Estimated completion is 2015-11.
What interventions are being tested in trial NCT01769469?
The interventions under investigation include: FTC/TDF (Truvada®) (DRUG).
Who is sponsoring clinical trial NCT01769469?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia